BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10586857)

  • 1. Genentech pays $200m over growth hormone 'theft'.
    Dalton R; Schiermeier Q
    Nature; 1999 Nov; 402(6760):335. PubMed ID: 10586857
    [No Abstract]   [Full Text] [Related]  

  • 2. Charges fly in $1bn hormone patent battle.
    Dalton R
    Nature; 1999 May; 399(6734):289. PubMed ID: 10360558
    [No Abstract]   [Full Text] [Related]  

  • 3. US jury split over hormone patent case..
    Dalton R
    Nature; 1999 Jun; 399(6736):512. PubMed ID: 10376586
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotech patents. Genentech, UC settle suit for $200 million.
    Barinaga M
    Science; 1999 Nov; 286(5445):1655. PubMed ID: 10610555
    [No Abstract]   [Full Text] [Related]  

  • 5. Startling revelations in UC-Genentech battle.
    Marshall E
    Science; 1999 May; 284(5416):883, 885-6. PubMed ID: 10357665
    [No Abstract]   [Full Text] [Related]  

  • 6. UC-Genentech trial.
    Henner D; Goeddel DV; Heyneker H; Itakura K; Tansura D
    Science; 1999 May; 284(5419):1465. PubMed ID: 10383322
    [No Abstract]   [Full Text] [Related]  

  • 7. Statement from Peter Seeburg.
    Seeburg PH
    Nature; 1999 May; 399(6734):298. PubMed ID: 10360565
    [No Abstract]   [Full Text] [Related]  

  • 8. UC-Genentech trial.
    Seeburg PH
    Science; 1999 May; 284(5419):1465-6. PubMed ID: 10383323
    [No Abstract]   [Full Text] [Related]  

  • 9. as Seeburg faces misconduct inquiry.
    Abbott A
    Nature; 1999 Jun; 399(6736):512. PubMed ID: 10376587
    [No Abstract]   [Full Text] [Related]  

  • 10. No winners in patent shootout.
    Barinaga M
    Science; 1999 Jun; 284(5421):1752-3. PubMed ID: 10391787
    [No Abstract]   [Full Text] [Related]  

  • 11. Genentech stands by original data.
    Henner DJ; Goeddel DV; Heyneker H; Itakura K; Yansura D; Ross M; Miozzari G
    Nature; 1999 May; 399(6734):297-8. PubMed ID: 10360564
    [No Abstract]   [Full Text] [Related]  

  • 12. Scientific misconduct. Researcher rebuked for 20-year-old misdeed.
    Hagmann M
    Science; 1999 Dec; 286(5448):2249-50. PubMed ID: 10636777
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotechs sue Columbia over fourth Axel patent.
    Howard K
    Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538
    [No Abstract]   [Full Text] [Related]  

  • 14. Ownership at too high a price?
    Nat Biotechnol; 2003 Sep; 21(9):953. PubMed ID: 12949537
    [No Abstract]   [Full Text] [Related]  

  • 15. Affymetrix in new patents row.
    Ledford H
    Nature; 2008 Jul; 454(7203):377. PubMed ID: 18650873
    [No Abstract]   [Full Text] [Related]  

  • 16. Theory of knowledge and biotech patents: worlds apart?
    Altamirano-Bustamante MM; de Hoyos A; Olivé L
    Nat Biotechnol; 2011 Nov; 29(11):977-8. PubMed ID: 22068530
    [No Abstract]   [Full Text] [Related]  

  • 17. Patents. Signature on visitor's form fuels Stanford v. Roche court battle.
    Marshall E
    Science; 2011 Apr; 332(6026):163. PubMed ID: 21474725
    [No Abstract]   [Full Text] [Related]  

  • 18. Intellectual property. Depth charges aimed at Columbia's 'submarine patent'.
    Marshall E
    Science; 2003 Jul; 301(5632):448. PubMed ID: 12881539
    [No Abstract]   [Full Text] [Related]  

  • 19. Equivalents in biotechnology patents.
    Auer HE
    Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574
    [No Abstract]   [Full Text] [Related]  

  • 20. Bungled law threatens Italian tech transfer.
    Meldolesi A
    Nat Biotechnol; 2001 Nov; 19(11):996-7. PubMed ID: 11689829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.